© Copyright Nostre Net
Market Overview
The global Neurology Devices Market was worth $9,242 million in 2018 and is predicted to reach $ 17,410 million by 2026, growing at an annual rate of 8.1 per cent between 2019 and 2026. Neurology is a discipline of medicine that focuses on problems with the nervous system, including the brain, blood vessels, muscles, and nerves. The treatment of neurological disorders like Alzheimer's, tumors, and Parkinson's disease with neurovascular devices like interventional devices, cerebrospinal fluid management devices, and others. Shunts, valves, and external drainage systems are also used in cerebrospinal fluid management devices to facilitate the flow of cerebrospinal fluid and remove excess fluid from the brain.
A shunt also provides an alternative fluid conduit by which the cerebrospinal fluid avoids obstacles in the brain's fluid compartments as well as acts whenever fluid absorption is otherwise impeded. The stent-created bypass relieves the extra fluid buildup which causes hydrocephalus. Furthermore, numerous other devices or instruments, like catheters, ultrasonic aspirators, stents, and stereotactic systems, are available on the market for the therapy of neurological devices market.
Key Players
Some of the key players in the global neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others
Market Segmentation
The cerebrospinal fluid management devices segment dominated the neurology devices market by product in 2018, and this trend is expected to continue over the projected period. It is due to an increase in the use of these devices for neurological device diagnosis. These management devices, for example, are frequently employed in the neurology diagnostics and treatment of multiple sclerosis, encephalitis, myelitis, and other neurological diseases.
The hospital segment captured the most market share by end-user in 2018, and this trend is expected to continue during the projected period. This is due to the simple accessibility of neurological devices in hospital settings and patients' preference for visiting hospitals for neurological device diagnosis and therapy.
Regional Classification
In 2018, the neurology devices market was dominated by North America, followed by Europe. Increased government funding for the R&D of novel neurological devices and a rise in prevalence of neurological disorders like Alzheimer's and Parkinson's disease are driving the overall expansion of the North American neurology devices market. Furthermore, the widespread availability of innovative neurological equipment and a well-developed healthcare infrastructure and the existence of major companies all contribute to the market's development.
However, due to a growth in the frequency of neurological illnesses and the availability of a big patient pool in this region, LAMEA is expected to develop at the fastest pace over the analysis period. Furthermore, major factors driving the area's neurology devices market development include rising per capita income in many nations, increased government initiatives to boost the healthcare sector, as well as a sharp rise in leading manufacturers' focus on expanding their geographic presence in emerging countries to capture the largest share of the neurology devices market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Medical Second Opinion Market is expected to reach $7.12 billion by 2025, with a CAGR of 19.1% over the forecast period of 2020-2025. After the original diagnosis, the patient may seek a second opinion from a medical professional. When the patient is unsatisfied with the prognosis or if there is a more need for validation within the case of some critical surgical operations, the patient might request a medical second opinion. Post the original diagnosis; the patient may seek a second opinion from a medical professional. Chronic diseases like ocular disorders, pulmonary disorders, neurological disorders, and nephrological disorders, which are driving the medical second opinion market over the projected period, have a significant need for a second opinion.
Market Segmentation
Medical second opinion depending on disorder kind Cardiac disorder, neurologic disorder, organ transplant, COPD, skin disorder, ocular disorder, kidney, nephrological disorder, urological disorder, and others are some of the market segments. In terms of revenue, the neurological illness segment had the highest share in 2019. It is due to a growing emphasis on lowering healthcare costs and increasing the incidence of neurological illnesses. During the projected period 2020-2025, COPD is expected to increase at the fastest rate of 19.7%. It is due to the rise in the prevalence and incidence of asthma, COPD patients, technological developments, and an ageing population.
The Medical Second Opinion Market is divided into Health Insurance Companies, Hospitals, Online and Offline Second Opinion Service Providers, medical second opinion services, Private Clinics, and Others based on the kind of service provided. In 2019, the hospital segment accounted for the majority of the market. This is due to the convenience they offer patients and the rising prevalence and incidence of technological breakthroughs, asthma and COPD, and the aging population. Throughout the forecast period 2020-2025, the market for online and offline second opinion service providers is expected to develop at the quickest rate. It is due to the increasing number of hospitals and online provider services and increased efficiency and service provider features, all of which are adding to the segment's development.
Regional Classification
The Medical Second Opinion Market is divided into Europe, North America, Asia-Pacific, and the World, depending on geography. In terms of revenue, North America dominated with an overall share of XX percent in 2019. It's due to a well-informed population, advanced healthcare infrastructure, and supportive government policies. During the prediction year 2020-2025, Europe is expected to have the highest CAGR. This is due to a rising need in European nations for enhanced diagnostic and treatment planning and lower financial costs and easier contact.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Scope of the Report
Market Research Future (MRFR) expects the nebulizers market to attain a valuation of USD 1,629.7 Million by the year 2027. It is also presumed that the market size will continue to soar at a rate of 7.32% between 2020 and 2027.
Top Boosters and Key Barriers
The COVID-19 outbreak has interestingly been opportune for the nebulizers industry. The rising cases of SARS-CoV-2 have pushed the demand for albuterol inhalers across hospitals for treating suspected patients suffering from respiratory issues. COVID-19 is a common facilitator of asthma or respiratory exacerbations, with the geriatric population deemed to be more susceptible to these health conditions. This demography is also highly prone to several respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), novel coronavirus as well as sleep apnea. In a nutshell, the burgeoning elderly population should foster the demand for nebulizers market in the upcoming years.
Drug wastage is one of the biggest challenges faced by the healthcare sector following device usage. Sensing the opportunity, several companies are coming up with highly innovative nebulizers such as vibrating mesh, breath-enhanced and breath-actuated nebulizers that cut down drug wastage and enhance the efficiency of drug delivery. Such nebulizers help elevate the output rate while reducing the entire administration period. Besides, the heightened demand for healthcare devices that can be used at home and the surging consumption of cigarettes, alcohol and tobacco that cause respiratory disorders should also enhance the market size in the years to come.
Companies Profiled
Braun Melsungen AG (Germany), Invacare Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US), Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the prominent firms in the global market.
Segmental Status
The nebulizers industry has been dissected with respect to type, usage, portability along with end user.
The nebulizer types that are available in the global market are jet, ultrasonic as well as mesh. The types of mesh nebulizers include passive and active. From the main types of nebulizers, the jet nebulizers types should procure the top position over the following years since they are far more cost-effective compared to other types in the market and should therefore, note higher demand.
Usage-wise, the major segments can be reusable and disposable. Out of these, the leading spot has been secured by disposable nebulizers, as these witness significant demand given the provision of reduced infection rate as well as wastage.
Portable and tabletop are identified as the main segments, as per portability. The portable nebulizers market has been progressing at the fastest pace, thanks to its convenient coupled with ease of use.
Home care, along with hospitals & clinics are the industry end-users covered in the MRFR study. In light of the expanding patient base, hospitals and clinics have emerged as the leading segment in the market. But, it is likely that the homecare segment will achieve the fastest growth rate in the years ahead.
Regional Status
Europe/EU, the Americas, Asia Pacific/APAC and Middle East and Africa/MEA are the key regions across which the nebulizers market is expected to note growth over the review period.
The American market has emerged the clear winner out of the regions, on account of the alarming growth in respiratory disorders and the favorable reimbursement schemes available in the region. The region’s performance will be further bolstered by the fact that consumers here follow a fast-moving lifestyle and therefore, opt for portable devices that are compact and have multiple advanced features. This scenario is also favored by the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is expected to attain higher growth in the coming years, in view of the fast-expanding elderly patient base affected by several respiratory diseases. Frequent technological advances and the emergence of new and more sophisticated nebulizers in the market should be favorable as well.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Overview
Electronic Trial Master File (eTMF) Systems Market is expected to reach a value of USD 1825 Million by 2025, at a CAGR of 13.11% during the assessment period of 2019 to 2025.
Market Dynamics
Electronic Trial Master File Systems have grown in favor across a variety of enterprises, including pharmaceutical and biotechnology firms, in the digital age. The eTMF Systems market is growing in popularity since the novel solution allows customers to get a real-time view of clinical papers and manage them effectively. The global eTMF systems market is growing due to a number of factors, including increased acquisitions, new solution and service deployments, and partnerships by leading market participants, as well as an increase in the number of clinical trial studies.
However, small and medium-sized businesses' budget constraints, as well as a scarcity of experienced people to operate electronic systems, may make such solutions less appealing. As a result, such factors may limit the market's expansion throughout the forecast period.
The etmf clinical trials has changed dramatically as a result of Covid 19. It has heightened the necessity to integrate digital technologies into therapeutic activities in order to reduce reliance on manual processes. The epidemic has provided an opportunity to efficiently and creatively record and maintain clinical trial documents. Organizations have turned to the eTMF systems idea to combine digitalization while handling clinical data to capitalize on the new opportunities in the post-Covid era.
Competitive Dynamics
The notable players of the market are Aurea, Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US), Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva Systems (US), and Wingspan (IQVIA) (US).
Segmental Analysis
The eTMF Systems Market can be divided into two categories based on their components: software and services. Both market categories have been performing well, and they are expected to contribute to the Electronic Trial Master File (eTMF) Systems Market's growth over the anticipated time.
The eTMF Systems Market can be divided into on-premise and web/cloud-based systems based on the deployment model. According to the eTMF Systems Market Forecast, the web/cloud segment will likely be the fastest-growing segment in the near future.
According on the end-user, the eTMF Systems Market can be segmented into contract research organizations, biotechnology and pharmaceutical businesses, and others. Due to the increased demand for exact master file solutions, contract research companies are likely to acquire a significant chunk of the Electronic Trial Master File (eTMF) Systems Market Share throughout the forecasted period.
Regional Overview
The global eTMF Systems Market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is the most important regional sector in terms of market growth on a worldwide scale. Oracle and Veeva Systems are two key players that control a considerable percentage of the Electronic Trial Master File (eTMF) Systems Market Value.
On a worldwide scale, the European market has been performing admirably. The high level of support from regulatory bodies is one of the market's primary drivers. The adoption of quickly growing technology in the market is one of the primary Electronic Trial Master File (eTMF) Systems market trends that is consistent across various regional sectors.
The Asia Pacific region is expected to perform well in the market over the anticipated period. Due to the rising adoption rate of eTMF software and services in Asian countries, the eTMF systems market in this region is expected to develop at the quickest rate throughout the assessment period.
The Middle East and Africa regional division is the smallest in terms of geographical area. The inadequate development of the region's healthcare infrastructure, as well as a lack of exposure to digital technologies and innovations, are the key factors for the eTMF Systems Market's limited growth. Each geographical division is projected to contribute to global market performance during the forecasted time.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Global Pain Patch Market size is expected to grow at a higher rate than before. Analysts believe that the market will witness a healthy growth at a CAGR of 4.8% during the forecast period 2019-2025. Market value for the pain patch market at global levels is expected to reach USD29.5 billion by 2025. Pain-relief patches also known as pain patches can be easily purchased from pharmacies. They are available in different types, however, most of the pain patches are used for managing both short-term and long-term pain. This clearly means that a pain patch can be prescribed for both acute and chronic pain conditions. This flexibility and effectiveness helps the companies in the global market for pain patch grow as the demand for these products remains strong throughout the year, and its easy availability has given more boost to the market.
A pain patch market when placed on the skin helps the skin absorb a certain amount of medication which helps prevent or reduce pain. The medication easily gets absorbed into the bloodstream, however the type of medication and patch prescribed by physicians may vary depending on the actual need of the patients and levels of the pain. Prescription based pain patches may include diclofenac epolamine, an anti-inflammatory nonsteroidal drug, a local anesthetic known as lidocaine, and opioid pain medication.
For minor injuries, physicians recommend a pain patch with diclofenac epolamine. This formula helps in reducing and controlling minor pain caused due to muscle strains and sprains. This element falls under the same group as ibuprofen and aspirin. Patients are asked to be careful and not use such patches anywhere on a broken skin. A study published by expert analysts has found that such pain patches can provide pain relief for soft-tissue injuries with few adverse effects.
Pain Patch Market Key Players
Pain Patch Market Segmentation
For the scope of research, analysts have segmented the pain patch market based on type, mode of administration, end users, and therapeutic use.
Pain Patch Market Regional Overview
Industry experts have analyzed the global pain patches market at different levels. The report brings information from across the world and provides key insights into regional pain patch markets from the Americas, which is the largest market in the world for pain patches. The growth here is due to an increasing number of patients with chronic diseases and spinal injury. The report also covers the European market where demand for pain patches is on the rise. Other regional pain patch markets covered in the report are Asia-Pacific and the Middle East and Africa. For each of these regions, analysts have also presented country-level trends, predictions, and market status details along with profiling of key players present in the global pain patch market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Forecast
Registering a CAGR of 8.57%, Transarterial Chemoembolization (TACE) Market is expected to grow from USD 1559.20 Million in 2018 to USD 2777.22 Million by 2025.
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and occurs mainly due to chronic liver disease and cirrhosis. It is the third leading cause of cancer deaths worldwide, with over 500,000 people affected. Transarterial chemoembolization market is the current standard of therapy for patients with intermediate-stage hepatocellular carcinoma (HCC). Conventional TACE is considered as a standard treatment for HCC.
Key Players
Segmentation
By Procedure Type
By Product Type
By End-User
By Region
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Synopsis
Market Research Future (MRFR) asserts that the global urinalysis test market is slated to demonstrate a stellar CAGR during the forecast period (2017-2023). The increased demand for point of care testing devices is likely to favor the market growth. Urinalysis is referred to as a urine test which is performed to detect and manage disorders like liver disease, urinary tract infections, diabetes, and kidney disease. A cost-effective and non-invasive analysis method, urinalysis involves checking the content, appearance, and concentration of the urine. These kinds of tests are highly recommended during a routine examination, pregnancy checkup, and pre-surgery preparation in order to detect any disease condition.
Market Potential and Pitfalls
The urinalysis market is growing at breakneck speed due to the rising demand for point of care testing devices, developing technologies in the field of diagnostics, and increased prevalence of chronic diseases across the globe. The cost-effectiveness along with the augmenting demand for urine automated urine analyzers are acting as push factors for the growth of the market. As per the National Institute of Diabetes and Digestive and Kidney Diseases, the prevalence of chronic kidney disease among the general population is about 14%. The urinalysis market has undergone several technological advancements which are further anticipated to boost the market across the globe as such advancements have proved to improve the reliability and efficiency of the results. Moreover, urine analyzers are integrated with Electronic Health Records in order to link the results directly into the database of the patient. Siemens AG has collaborated with Relaymed in order to bring labs cloud-based connectivity for Clinitek Status POC instruments and the Siemens DCA Vantage analyzer. With the change in lifestyle and increasing incidences of chronic diseases, there is an increased demand for advanced and quick tests, which has further resulted in the growth of the market.
Competitive Dashboard
The prominent players operating in the urinalysis test market are Dahaner (U.S.), ARKRAY Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Sysmex Corporation (Japan), Siemens AG (U.S.), Bio-Rad Laboratories Inc. (U.S.), and ACON Laboratories Inc. (U.S.).
Global Urinalysis Test Market: Segmental Analysis
The global urinalysis test market has been segmented on the basis of test type, product type, end user, and application.
By mode of product type, the global urinalysis test market has been segmented into consumables and instruments. Among these, the consumables are expected to hold a significant share in the global market owing to its extensive use in the disposables in urinalysis research and testing. Moreover, the advent of advanced reagents and use of disposables are likely to favor the growth of the segment.
By mode of test type, the global urinalysis test market has been segmented into biochemical urinalysis, macroscopic urinalysis, urinalysis analyzer and sediments/microscopic urinalysis. Among these, the biochemical urinalysis is likely to occupy a significant share owing to the rapidly increasing geriatric population coupled with the increased incidences of kidney diseases and urinary tract infections.
By mode of application, the global urinalysis test market has been segmented into disease diagnosis comprising diagnosis of diseases like liver disease, kidney disease, pregnancy tests, diabetes, and others.
By mode of end-users, the global urinalysis test market has been segmented into independent laboratories, hospitals, and physician practices.
Regional Insights
Geographically, the urinalysis test market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, America is considered to occupy the largest market share due to the increased demand for automated urine analyzers, accelerating incidences of liver and kidney diseases, and technological advancements in this region. In the North American region, the U.S. is estimated to hold the major share due to the high concentration of market giants manufacturing consumables and urine analyzers.
Europe occupies the second position and is anticipated to expand at a steady pace. The growth is credited to the rising prevalence of chronic diseases such as diabetes. Moreover, the availability of cost-effective treatment coupled with the rising funding from the government for R&D activities is further triggering the demand for urinalysis test in this region.
The Asia Pacific is presumed to grow at the fastest rate due to the augmenting incidences of chronic diseases such as kidney, diabetes, and others. Moreover, with the changing lifestyle and increasing demand for urine analyzers, the market is likely to boom in this region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Analysis
The global healthcare enterprise software market is expected to touch USD 76.45 billion at a staggering 13.0 % CAGR during the forecast period. Healthcare software is used by nursing homes and hospitals for managing data both clinical and non-clinical. It helps in maintaining patient records electronically resulting in hassle-free storage and retrieval. Such software aids in managing, securing and analyzing information precisely in healthcare environment. Ample data can be stored here rather than handling records manually.
There are abundant factors that is propelling the growth of the healthcare enterprise software market. These factors as per the MRFR (Market Research Future) report include increase in software solutions available exclusively for healthcare management, increasing global competition, increasing awareness about enterprises software, introduction of new software services, technological advancement and innovation, entry of novel industry players, increasing number of enterprises across the world, strict rule governing the patient information management and attention on electronic health records. On the contrary, price of the software solution is likely to impede the growth of the many healthcare facilities now use voice recognition software for transcription.
Key Players
Leading players profiled in the healthcare enterprise software market include CompuGroup (UK), Medidata Solutions (US), Athenahealth (US), Cerner Corporations (US), McKesson Corporation (US), Infosys Ltd. (U.S), Cognizant Technology Solutions Corporation (U.S.), IBM Corporation (U.S), Allscripts Healthcare Solutions (U.S), and Microsoft Corporation (U.S).
Market Segmentation
MRFR report offers a broad segmental analysis of the healthcare enterprise software market on the basis of types, mode of delivery, applications and end users.
Based on types, it is segmented into billing, HR management software, laboratory management software, OT management software, scheduling software, inventory management software, patient registration software and others.
Based on mode of delivery, the healthcare enterprise software market is segmented into cloud base and on-premise.
Based on application, it is segmented into non-clinical, clinical and others.
Based on end users, the healthcare enterprise software market is segmented into pharmacy, clinics, hospitals and others.
Regional Analysis
By region, the healthcare enterprise software market covers growth opportunities and latest trends across Americas, Europe, Asia Pacific and Middle East and Africa. Of these, Americas will remain the largest market over the forecast period owing to growing need for software solutions to manage patient’s medical records coupled with increasing utilization of information technology (IT) in hospitals. Factors that are imparting towards the growth of the healthcare enterprise software market in this region include extensive utilization of software solutions for healthcare management, use of electronic records over manual records, growing significance of electronic health records, advancement in technology in software development, health record maintenance, awareness amid patients regarding significance of their medical records as well as, legal applications, and demand for software solutions that are user friendly. In the US the leading healthcare IT and medical device companies are global leaders in offering healthcare software solutions and manufacturing medical components and devices. The healthcare enterprise software market in Europe will have the second major share due to rise in use of IT for healthcare management. This market is expanding constantly and catching up slowly with the market in North America. In the APAC region, the healthcare enterprise software market is expected to grow at the fastest pace owing to increasing awareness regarding the software coupled with use of electronic records over manual records. Diagnostic devices are showing an increasing and positive growth in the market. Toshiba Medical Systems Corporation is one of the key market players in this region. The demand for healthcare outreaching supplies, population growth and increasing disease burden is driving the growth of the market in this region. On the other hand, the healthcare enterprise software market in the Middle East and Africa is anticipated to show a steady growth over the forecast period.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Overview:
Amniotic membrane is quite important for body to initiate healing. It is a combination of tissues and cells, which acts as a foundation for re-growth of soft tissues. Amniotic membrane has wide-scale utility in eye surgery that acts like a biological bandage. The process heals or replaces eye tissues that are damaged. The global amniotic membrane market is all set to garner USD 1,210.9 million during the forecast period (2018-2023) with a CAGR of 12.16%. Market Research Future (MRFR) declared the possibility for the amniotic membrane market exceeding the predicted valuation is quite high.
The amniotic membrane market can rely on substantial surge in amniotic membrane-based transplantations globally. Also, health-related awareness is on the rise, which is expected to spur the global market growth.
Competitive Landscape:
Several companies are experiencing substantial growth due to the surge in the ingress level of the amniotic membrane market. These companies have been profiled by MRFR in their report on the same market for a better understanding of strategic moves and trends that can inspire market change. These companies are Applied Biologics (US), Alliqua BioMedical, Inc. (US), Integra LifeSciences (US), Skye Biologics Inc. (California), MiMedx (US), Amniox Medical, Inc. (Florida), Katena Products, Inc. (US), Human Regenerative Technologies, LLC (US), Amnio Technology, LLC (US), and Osiris Therapeutics, Inc. (US).
Segmentation:
MRFR’s analysis of the amniotic membrane market is based on an extensive segmentation that includes type, application, and end-user. This segmentation gets solid backup from the value-wise and volume-wise analysis of the market.
Based on the type, the global amniotic membrane market can be segmented into cryopreserved and lyophilized. traditional therapy was followed by placement of a dehydrated amniotic membrane allograft and the healing time course was documented with charted measurements. The cryopreservation amniotic membrane segment has better potential to lead the market with an impressive CAGR to reach USD 1,090.08million by the end of 2023. This is expected to get driven by the rising number of ocular surgeries. The lyophilized amniotic membrane segment, on the other hand, can project the highest CAGR of 14.18% during the forecast period. This growth is expected to rely mostly on rising number of surgeries, reconstruction procedures, cosmetic surgeries, and venous & pressure leg ulcers.
Based on the application, the global amniotic membrane market can be segmented into surgical wounds, ophthalmology, stem cell biology, regenerative medicine, and others. The ophthalmology segment is expected to fetch in substantial market due to wide-scale use of amniotic membrane in the segment.
Based on the end-user, the amniotic membrane market can be segmented into hospitals & clinics and others. The hospitals & clinics segment is expected to gain more as patients prefer the segment more.
Regional Analysis:
MRFR in their region-specific take on the global amniotic membrane market includes namely, the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). This region-specific segmentation allows a closer look at the growth pockets that unravels later market possibilities.
The Americas had the largest market share and it covered around 37.6% in 2017 and at present, it is slated to score an impressive CAGR of 13.28%during the forecast period. The APAC market is geared up to record the fastest CAGR during the forecast period. It has a huge market potential and can achieve 13.60% CAGR during the forecast period.
Europe has the potential to surpass USD 681.71 million valuation by 2023. Several issues like pterygium, cicatricial pemphigoid & Stevens-Johnson syndrome, conjunctival surface reconstruction, persistent epithelial defects with ulceration, and ocular surface reconstruction in patients with chemical & thermal burns in Europe are steering the amniotic membrane market growth in Europe. Germany makes a major impact and France is following Germany’s lead.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The global diabetic ulcer treatment market is expected to display a CAGR of 8.5% over the forecast period. It was valued at USD 7500 million in 2018. The large healthcare expenditure of nations in Europe, Americas, and other developing countries can drive the diabetic ulcer treatment market growth exponentially. Rising number of diabetics has driven the need for diabetic ulcer treatment. According to the American College of Physicians, diabetic foot ulcers statistics accounted to 6.3% cases annually. Standards outlined by healthcare organizations for getting annual foot exams annually can work in favor of the diabetic ulcer treatment market.
Diabetic ulcers are open wounds that appear in diabetics at the bottom of their foot. It is most commonly found in older men. Treatment of ulcers and amputations caused by these cost massive hospitalization fees and has triggered the need for effective therapies and methods. The global diabetic ulcer treatment market report by Market Research Future (MRFR) looks at amputations and neurological indications of these ulcers and predicts the future of their treatments for the period of 2019 to 2025 (forecast period).
Diabetic Ulcer Treatment Market Competitive Outlook
Cardinal Health, Integra LifeSciences Corporation, ACELITY L.P. INC., Essity Aktiebolag, Smith & Nephew PLC, Organogenesis Inc., Mölnlycke Health Care AB, Braun Melsungen AG, SANUWAVE Health, Inc., ConvaTec Group PLC, and 3M are some of the notable players profiled in the global diabetic ulcer treatment market. Mergers, new product launches, and acquisitions are prime strategies of the players in the market. Recently, Organogenesis Holdings Pvt Ltd. has launched biomaterials in an effort to expand its wound dressing product line and to appeal to patient demand. Clinical trials are also being conducted to test the efficacy and performance of treatments.
Diabetic Ulcer Treatment Market Segmentation
The Global Diabetic ulcer treatment market has been segmented by type, treatment, and end-user.
By type, Diabetic Ulcer Treatment Market has been divided into foot ulcer and mouth ulcer. The foot ulcer segment accounted for a large share of the global market. The primary factor driving the segment growth is the complications arising due to diabetes mellitus and the large pool of patients. Use of wound dressings and biologics for lowering the rate of amputations and successful treatment of DFU can drive the diabetic foot ulcer market during the forecast period.
By treatment, the diabetic ulcer treatment market is segmented into active therapies, wound care dressings, diabetic foot ulcer treatment products and wound care devices. Wound dressing held the largest share of the market due to the large number of diabetics.
By end-user, the diabetic ulcer treatment market is segmented into academic and research organizations, hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics accounted for the largest market share due to awareness campaigns by governments and favorable reimbursement schemes. Launch of mobile applications for creating awareness among the masses has successfully driven patients towards hospitals and clinics for diabetic ulcer treatment.
Diabetic Ulcer Treatment Market Regional Analysis
Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and Americas are regions covered with respect to the global diabetic ulcer treatment market.
The Americas can spur the demand for diabetic ulcer treatment due to the large number of cases of diabetics. According to the American Podiatric Medical Association, close to 14-24% of Americans with diabetic foot ulcers have undergone amputations. The high potential of the combination of debridement and continuous diffusion of oxygen (CDO) has seen successful outcomes in treatment of diabetic foot ulcers (DFU).
APAC can display a robust growth rate during the forecast period owing to a large patient pool and the developing healthcare sector in India and China.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America